Lost password ?
Gulf Pharmaceutical
Lower results in Q3
- "Julphar has missed our estimates in Q3. Revenues increased by 14.6% to reach AED415.8m. In the nine months, revenues jumped by 68% to AED1.25bn (+78.9% expected for the full year). "
Executive summary
Conflicts of Interest
FIND A REPORT
SIMPLE, TO THE POINT IDEA GENERATION
Each company is researched in depth using a structured, robust and transparent process. Valuations are disciplined and dispassionate.
AlphaMena allows you to compare stocks along a wide range of parameters be it by sector, by geography or an array of investment themes.
Our reports include actuarial as well as off balance-sheet data and governance metrics.
Priority is given to idea generation through quick, to the point, answers by means of browsing from one idea to the next.